Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Transmedics, Inc.

http://www.transmedics.com/

Latest From Transmedics, Inc.

TransMedics Announces Approval Of Heart Transplant Device

The OCS Heart System is expected to expand the number of hearts available for transplant.

Regulation Approvals

TransMedics Liver Transplant Device Gets July Panel Date

The US FDA panel will look at a PMA for the TransMedics OCS Liver System, which helps keep donor livers stable and healthy as they await transplant.

Regulation FDA

Global Device Approvals Snapshot: 28 May-3 June 2019

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week’s approvals include the US FDA's approval of a panel-track supplement for TransMedics' OCS Lung system to preserve donor lungs that would not be salvageable using a traditional cold static system.

Approvals Innovation

TransMedics Earns Second PMA For OCS Lung System

FDA approved a PMA supplement to allow TransMedics' Organ Care System (OCS) to be used for the preservation and ex-vivo assessment of lungs that would not be acceptable for transplant if they had been preserved with a standard cold static system.

Approvals Innovation
See All

Company Information

  • Industry
  • Medical Devices
UsernamePublicRestriction

Register